RUA Stock Overview
Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.
Rua Bioscience Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NZ$0.24|
|52 Week High||NZ$0.53|
|52 Week Low||NZ$0.23|
|1 Month Change||4.26%|
|3 Month Change||-16.95%|
|1 Year Change||-37.18%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-63.97%|
Recent News & Updates
Here's Why We're Not Too Worried About Rua Bioscience's (NZSE:RUA) Cash Burn SituationMay 13
Companies Like Rua Bioscience (NZSE:RUA) Are In A Position To Invest In GrowthDec 17
Here's Why We're Not Too Worried About Rua Bioscience's (NZSE:RUA) Cash Burn SituationJul 02
Here's Why We're Not Too Worried About Rua Bioscience's (NZSE:RUA) Cash Burn SituationMar 09
|RUA||NZ Pharmaceuticals||NZ Market|
Return vs Industry: RUA underperformed the NZ Pharmaceuticals industry which returned -26.1% over the past year.
Return vs Market: RUA underperformed the NZ Market which returned -14.5% over the past year.
|RUA Average Weekly Movement||6.9%|
|Pharmaceuticals Industry Average Movement||9.6%|
|Market Average Movement||4.1%|
|10% most volatile stocks in NZ Market||6.9%|
|10% least volatile stocks in NZ Market||2.9%|
Stable Share Price: RUA is more volatile than 75% of NZ stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: RUA's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of NZ stocks.
About the Company
Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. It offers cannabinoid derived medicines. The company was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019.
Rua Bioscience Limited Fundamentals Summary
|RUA fundamental statistics|
Is RUA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|RUA income statement (TTM)|
|Cost of Revenue||NZ$128.64k|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.058|
|Net Profit Margin||-1,338.73%|
How did RUA perform over the long term?See historical performance and comparison